MARKET

ISEE

ISEE

IVERIC bio Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

16.22
-0.40
-2.41%
After Hours: 16.44 +0.22 +1.36% 19:45 09/20 EDT
OPEN
16.00
PREV CLOSE
16.62
HIGH
16.46
LOW
15.87
VOLUME
1.64M
TURNOVER
--
52 WEEK HIGH
17.03
52 WEEK LOW
4.870
MARKET CAP
1.69B
P/E (TTM)
-14.0057
1D
5D
1M
3M
1Y
5Y
60 Biggest Movers From Friday
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic atrophy. IVERIC Bio, a competitor to Apellis, is also working on a...
Benzinga · 09/13 09:07
Hot Stocks: Game makers climb on AAPL news; CCJ sets high; ECHO buyout deal; bad data for APLS, MRSN
Apple grabbed headlines Friday with a court ruling in its ongoing legal battle with Epic Games. While the decision weighed down AAPL shares, it had a more positive influence on
Seekingalpha · 09/10 21:16
Iveric Bio to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
NEW YORK, September 10, 2021--Iveric announced that Pravin Dugel, M.D., President, will present an overview of the Company at the 2021 H.C. Wainwright Global Investment Conference.
Business Wire · 09/10 20:05
Mid-Afternoon Market Update: Dow Slides Over 100 Points; Echo Global Logistics Shares Spike Higher
Toward the end of trading Friday, the Dow traded down 0.31% to 34,772.74 while the NASDAQ fell 0.27% to 15,207.42. The S&P also fell, dropping 0.28% to 4,480.86.
Benzinga · 09/10 19:07
8 Health Care Stocks With Unusual Options Alerts In Today's Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. Unusual trading activity could push option price...
Benzinga · 09/10 17:39
ATER, CEI and RLX among mid-day movers
Gainers: IVERIC (NASDAQ:ISEE) +62%. Echo (NASDAQ:ECHO) +53%. Endo International plc (NASDAQ:ENDP) +35%. Affirm (NASDAQ:AFRM) +32%. Elite Education (NASDAQ:EEIQ) +30%. SigmaTron (NASDAQ:SGMA) +25%. Onion Global (NYSE:OG) +21%. Farmmi (NASDAQ:FAMI) +20%. Ate...
Seekingalpha · 09/10 16:36
Mid-Day Market Update: Crude Oil Rises Over 2%; Apellis Pharmaceuticals Shares Plunge
Midway through trading Friday, the Dow traded down 0.40% to 34,739.37 while the NASDAQ fell 0.06% to 15,238.92. The S&P also fell, dropping 0.21% to 4,483.84.
Benzinga · 09/10 16:31
41 Stocks Moving In Friday's Mid-Day Session
Gainers
Benzinga · 09/10 16:23
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ISEE. Analyze the recent business situations of IVERIC bio Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ISEE stock price target is 22.00 with a high estimate of 25.00 and a low estimate of 20.00.
EPS
Institutional Holdings
Institutions: 180
Institutional Holdings: 91.21M
% Owned: 87.69%
Shares Outstanding: 104.01M
TypeInstitutionsShares
Increased
39
5.51M
New
24
5.22M
Decreased
39
5.28M
Sold Out
12
618.62K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-2.58%
Pharmaceuticals & Medical Research
-1.08%
Key Executives
President
Pravin Dugel
Chief Executive Officer/Director
Glenn Sblendorio
Chief Financial Officer/Senior Vice President/Treasurer
David Carroll
Chief Operating Officer/Senior Vice President
Keith Westby
Senior Vice President
Christopher Simms
Lead Director/Independent Director
Adrienne Graves
Independent Director
Mark Blumenkranz
Independent Director
Axel Bolte
Independent Director
Jane Henderson
Independent Director
Calvin Roberts
No Data
About ISEE
IVERIC bio, Inc. is a biopharmaceutical company. The Company is engaged in the discovery and development of treatment options for retinal diseases. The Company is developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases (IRDs). The Company's therapeutics portfolio consists of Zimura (avacincaptad pegol), a complement C5 inhibitor, and IC-500, a high-temperature requirement A serine peptidase 1 protein (HtrA1) inhibitor. The Company's gene therapy portfolio consists of two product candidates in pre-clinical development, IC-100 and IC-200. The Company is developing IC-100 for rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) and IC-200 for bestrophin-1 (BEST1) related IRDs.

Webull offers kinds of IVERIC bio Inc stock information, including NASDAQ:ISEE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ISEE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ISEE stock methods without spending real money on the virtual paper trading platform.